Gülbanu Güner
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Gülbanu Güner has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Fatma Kulali
Department of Radiology, University of Health Sciences, Umraniye Training and Research Hospital, Istanbul, Turkiye
3 shared publications - Sevde Nur Emir
University of Health Sciences, Umraniye Training and Research Hospital, Department of Radiology, Istanbul, Turkey
3 shared publications Ahmet Harun Turgan
Health Sciences University, Umraniye Training and Research Hospital, Department of Radiology, Istanbul, Turkey
1 shared publication- Ayse Silan Kapuci
Department of Radiology, University of Health Sciences Umraniye Training and Research Hospital, Umraniye, Turkey
1 shared publication - Görkem Karamustafao
Department of Radiology, University of Health Sciences, Umraniye Training and Research Hospital, Istanbul, Turkey
1 shared publication - Servet Emir
Department of Internal Medicine, University of Health Sciences, Umraniye Training and Research Hospital, Istanbul, Turkey
1 shared publication
Latest Publications
- 23 October 2026
- Published by Elsevier in Clinical Radiology
- Vol. 103, 107509
Diagnostic performance of the Kaiser score in differentiating histopathologic subgroups of intraductal papillomas on breast magnetic resonance imaging
- 23 October 2026
- Published by Elsevier in Clinical Radiology
- Vol. 103, 107509
Diagnostic performance of the Kaiser score in differentiating histopathologic subgroups of intraductal papillomas on breast magnetic resonance imaging
- Open Access
- 24 November 2025
- Published by Springer Nature in Cancer Imaging
- Vol. 25 (1) , 133
Can abbreviated MRI replace standard protocols in IPMN surveillance? A retrospective comparative study
With the advancements in imaging technologies and the widespread use of magnetic resonance imaging (MRI), the detection rates of pancreatic cystic lesions (PCLs) have significantly increased. While most of these lesions are benign, branch-duct intraductal papillary mucinous neoplasms (BD-IPMNs) pose a potential risk for malignant transformation, necessitating regular clinical and radiological follow-up. However, conventional MRI protocols are time-consuming and resource-intensive, prompting the need for shorter, cost-effective alternatives without compromising diagnostic accuracy. This study aims to evaluate the diagnostic performance and clinical feasibility of abbreviated MRI (A-MRI) protocols for BD-IPMN surveillance compared to standard MRI (S-MRI). This was a single-center, retrospective study including patients with BD-IPMN who underwent follow-up MRI between January 2022 and December 2024. Three MRI protocols were analyzed: (1) S-MRI, comprising T2-weighted imaging, dynamic contrast-enhanced (DCE) T1-weighted imaging, 3D MR cholangiopancreatography (MRCP), and diffusion-weighted imaging (DWI); (2) A-MRI protocol 1 (A-MRI-1), including MRCP and T2-weighted sequences; and (3) A-MRI protocol 2 (A-MRI-2), incorporating MRCP, T2-weighted, and DWI sequences. The images were evaluated for lesion size progression (≥ 5 mm in 2 years), mural nodules, cyst wall thickening, main pancreatic duct dilation, and parenchymal atrophy. Sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) were calculated for A-MRI protocols in detecting degeneration signs. A total of 124 patients (mean age: 64 years, 55.6% female) and 124 lesions were analyzed. The detection rates of key degeneration markers were similar between S-MRI and A-MRI protocols, except for contrast-enhanced mural nodules, which were not identifiable with A-MRI due to the lack of DCE sequences. The overall sensitivity, specificity, PPV, and NPV for A-MRI in detecting BD-IPMN degeneration markers were 100%, 98.3%, 71.4%, and 100%, respectively. A-MRI protocols demonstrated a comparable diagnostic performance to S-MRI while significantly reducing scan time (from ~ 40–50 min to 7–12 min). However, false-positive mural nodule detection was higher with A-MRI, potentially leading to unnecessary follow-up imaging. The addition of DWI in A-MRI-2 did not provide a significant diagnostic advantage over A-MRI-1. A-MRI is a viable alternative for BD-IPMN follow-up, offering substantial reductions in imaging duration and costs while maintaining high diagnostic accuracy. However, the absence of DCE sequences may lead to false-positive mural nodule detection, necessitating further evaluation in selected cases.
- 24 November 2025
- Published by Springer Nature in Cancer Imaging
- Vol. 25 (1) , 133
Open AccessCan abbreviated MRI replace standard protocols in IPMN surveillance? A retrospective comparative study
With the advancements in imaging technologies and the widespread use of magnetic resonance imaging (MRI), the detection rates of pancreatic cystic lesions (PCLs) have significantly increased. While most of these lesions are benign, branch-duct intraductal papillary mucinous neoplasms (BD-IPMNs) pose a potential risk for malignant transformation, necessitating regular clinical and radiological follow-up. However, conventional MRI protocols are time-consuming and resource-intensive, prompting the need for shorter, cost-effective alternatives without compromising diagnostic accuracy. This study aims to evaluate the diagnostic performance and clinical feasibility of abbreviated MRI (A-MRI) protocols for BD-IPMN surveillance compared to standard MRI (S-MRI). This was a single-center, retrospective study including patients with BD-IPMN who underwent follow-up MRI between January 2022 and December 2024. Three MRI protocols were analyzed: (1) S-MRI, comprising T2-weighted imaging, dynamic contrast-enhanced (DCE) T1-weighted imaging, 3D MR cholangiopancreatography (MRCP), and diffusion-weighted imaging (DWI); (2) A-MRI protocol 1 (A-MRI-1), including MRCP and T2-weighted sequences; and (3) A-MRI protocol 2 (A-MRI-2), incorporating MRCP, T2-weighted, and DWI sequences. The images were evaluated for lesion size progression (≥ 5 mm in 2 years), mural nodules, cyst wall thickening, main pancreatic duct dilation, and parenchymal atrophy. Sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) were calculated for A-MRI protocols in detecting degeneration signs. A total of 124 patients (mean age: 64 years, 55.6% female) and 124 lesions were analyzed. The detection rates of key degeneration markers were similar between S-MRI and A-MRI protocols, except for contrast-enhanced mural nodules, which were not identifiable with A-MRI due to the lack of DCE sequences. The overall sensitivity, specificity, PPV, and NPV for A-MRI in detecting BD-IPMN degeneration markers were 100%, 98.3%, 71.4%, and 100%, respectively. A-MRI protocols demonstrated a comparable diagnostic performance to S-MRI while significantly reducing scan time (from ~ 40–50 min to 7–12 min). However, false-positive mural nodule detection was higher with A-MRI, potentially leading to unnecessary follow-up imaging. The addition of DWI in A-MRI-2 did not provide a significant diagnostic advantage over A-MRI-1. A-MRI is a viable alternative for BD-IPMN follow-up, offering substantial reductions in imaging duration and costs while maintaining high diagnostic accuracy. However, the absence of DCE sequences may lead to false-positive mural nodule detection, necessitating further evaluation in selected cases.
- 1 June 2025
- Published by Elsevier in European Journal of Radiology
- Vol. 190, 112211
Diagnostic performance of abbreviated breast MRI in differentiating intraductal papilloma from ductal secretion
- 1 June 2025
- Published by Elsevier in European Journal of Radiology
- Vol. 190, 112211
Diagnostic performance of abbreviated breast MRI in differentiating intraductal papilloma from ductal secretion
- 9 January 2025
- Published by Elsevier in Journal of Clinical Densitometry
- Vol. 28 (2) , 101561
Evaluation of lumbar vertebral bone quality using T1-weighted MRI: Can it differentiate normal, osteopenia, and osteoporosis?
- 9 January 2025
- Published by Elsevier in Journal of Clinical Densitometry
- Vol. 28 (2) , 101561
Evaluation of lumbar vertebral bone quality using T1-weighted MRI: Can it differentiate normal, osteopenia, and osteoporosis?
- 26 November 2021
- Published by Wiley in Journal of Ultrasound in Medicine
- Vol. 41 (8) , 2071-2077
Outcomes in Sonographically Categorized Complex Cystic Breast Lesions
Objectives: To investigate outcomes of patients with complex cystic breast lesions and to determine malignancy rates for each sonographic category.Material and Methods: A total of 124 women with a mean age of 45 were enrolled in this retrospective study. Complex cysts were classified into four categories according to sonographic findings (thick septa/wall, intramural nodule, solid/cystic ratio) by two radiologists. Size, margin, short‐to‐long axis ratio, and vascularity were also noted. The relationship between sonographic features and histopathological/follow‐up results was evaluated.Results: Of 124 complex cysts, 11 were malignant and 113 were benign. There were 31 with thick septa/wall (category 1), 14 with intramural nodule (category 2), 60 with solid/cystic ratio < 1 (category 3), and 19 with solid/cystic ratio > 1 (category 4). Among 11 malignant tumors, six intraductal papillary carcinomas and three invasive ductal carcinomas were in category 3, whereas one invasive ductal carcinoma was in category 1 and one was in category 4. Most of malignant lesions (9/11, 82%) were in category 3. Most of benign lesions (96/113, 85%) were fibroadenomatoid/fibrocystic changes. The presence of vascularity (96%), irregular margin (94%), and short‐to‐long axis ratio ≥ 1 (94%) had higher accuracy rates for diagnosis of malignancy.Conclusion: The malignancy rate was 8.8% in our study. Besides internal morphological features, other sonographic features should be considered in the evaluation of complex cystic breast lesions. Due to substantial risk of malignancy and the overlapping sonographic features of benign and malignant lesions, tissue sampling of all complex cysts should be performed.
- 26 November 2021
- Published by Wiley in Journal of Ultrasound in Medicine
- Vol. 41 (8) , 2071-2077
Outcomes in Sonographically Categorized Complex Cystic Breast Lesions
Objectives: To investigate outcomes of patients with complex cystic breast lesions and to determine malignancy rates for each sonographic category.Material and Methods: A total of 124 women with a mean age of 45 were enrolled in this retrospective study. Complex cysts were classified into four categories according to sonographic findings (thick septa/wall, intramural nodule, solid/cystic ratio) by two radiologists. Size, margin, short‐to‐long axis ratio, and vascularity were also noted. The relationship between sonographic features and histopathological/follow‐up results was evaluated.Results: Of 124 complex cysts, 11 were malignant and 113 were benign. There were 31 with thick septa/wall (category 1), 14 with intramural nodule (category 2), 60 with solid/cystic ratio < 1 (category 3), and 19 with solid/cystic ratio > 1 (category 4). Among 11 malignant tumors, six intraductal papillary carcinomas and three invasive ductal carcinomas were in category 3, whereas one invasive ductal carcinoma was in category 1 and one was in category 4. Most of malignant lesions (9/11, 82%) were in category 3. Most of benign lesions (96/113, 85%) were fibroadenomatoid/fibrocystic changes. The presence of vascularity (96%), irregular margin (94%), and short‐to‐long axis ratio ≥ 1 (94%) had higher accuracy rates for diagnosis of malignancy.Conclusion: The malignancy rate was 8.8% in our study. Besides internal morphological features, other sonographic features should be considered in the evaluation of complex cystic breast lesions. Due to substantial risk of malignancy and the overlapping sonographic features of benign and malignant lesions, tissue sampling of all complex cysts should be performed.